Carly Conran

521 total citations
18 papers, 309 citations indexed

About

Carly Conran is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Carly Conran has authored 18 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Carly Conran's work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Carly Conran is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Carly Conran collaborates with scholars based in United States, China and Hong Kong. Carly Conran's co-authors include Deke Jiang, Larry W. Moreland, Bin Zhou, Jinlin Hou, Yuan Ji, Amy S. B. Bohnert, Stephen T. Chermack, Jodie Trafton, Mary Jannausch and Mark A. Ilgen and has published in prestigious journals such as PLoS ONE, Hepatology and Addiction.

In The Last Decade

Carly Conran

18 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carly Conran United States 11 81 80 77 58 53 18 309
Ryan Lamm United States 11 71 0.9× 72 0.9× 33 0.4× 42 0.7× 72 1.4× 32 316
Polyxeni Dimitropoulou United Kingdom 9 41 0.5× 37 0.5× 93 1.2× 25 0.4× 19 0.4× 12 279
Victor Palit United Kingdom 10 92 1.1× 45 0.6× 122 1.6× 39 0.7× 7 0.1× 29 392
Anastasia Tsagianni United States 9 65 0.8× 66 0.8× 24 0.3× 13 0.2× 89 1.7× 15 325
Fatma Soliman Elsayed Ebeid Egypt 11 38 0.5× 48 0.6× 34 0.4× 11 0.2× 26 0.5× 58 347
James Pine United Kingdom 11 47 0.6× 35 0.4× 72 0.9× 75 1.3× 113 2.1× 22 532
Markus S. Jördens Germany 11 49 0.6× 105 1.3× 51 0.7× 31 0.5× 63 1.2× 37 320
Maria Skondra Greece 11 73 0.9× 35 0.4× 86 1.1× 42 0.7× 23 0.4× 27 292
J Chlumský Czechia 10 55 0.7× 32 0.4× 309 4.0× 30 0.5× 18 0.3× 42 435
Hakan Yüceyar Türkiye 13 99 1.2× 57 0.7× 37 0.5× 26 0.4× 38 0.7× 36 357

Countries citing papers authored by Carly Conran

Since Specialization
Citations

This map shows the geographic impact of Carly Conran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carly Conran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carly Conran more than expected).

Fields of papers citing papers by Carly Conran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carly Conran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carly Conran. The network helps show where Carly Conran may publish in the future.

Co-authorship network of co-authors of Carly Conran

This figure shows the co-authorship network connecting the top 25 collaborators of Carly Conran. A scholar is included among the top collaborators of Carly Conran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carly Conran. Carly Conran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Conran, Carly, Jason Kolfenbach, Kristine A. Kuhn, Christopher C. Striebich, & Larry W. Moreland. (2023). A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management. Current Rheumatology Reports. 25(12). 285–294. 14 indexed citations
2.
Conran, Carly & Larry W. Moreland. (2022). A review of biosimilars for rheumatoid arthritis. Current Opinion in Pharmacology. 64. 102234–102234. 15 indexed citations
3.
Conran, Carly, Zhuqing Shi, Rong Na, et al.. (2021). Assessing the clinical utility of genetic risk scores for targeted cancer screening. Journal of Translational Medicine. 19(1). 41–41. 6 indexed citations
4.
Sun, Jian, Bin Zhou, Qing Xie, et al.. (2020). A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. 51(4). 469–478. 14 indexed citations
5.
Jiang, Deke, Jiaen Deng, Changzheng Dong, et al.. (2020). Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma. BMC Cancer. 20(1). 403–403. 7 indexed citations
6.
Zhou, Bin, Li Liu, Fu Yang, et al.. (2019). Molecular pattern of lncRNAs in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 198–198. 47 indexed citations
7.
Sun, Jian, Bin Zhou, Qing Xie, et al.. (2019). Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha. Clinical Gastroenterology and Hepatology. 18(1). 196–204.e8. 19 indexed citations
8.
Helfand, Brian T., Haitao Chen, Richard J Fantus, et al.. (2018). Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score. The Prostate. 78(14). 1063–1068. 1 indexed citations
9.
Na, Rong, Yishuo Wu, Guangliang Jiang, et al.. (2018). Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. British Journal of Urology. 122(5). 808–813. 11 indexed citations
10.
Zhang, Song, Qianyi Xiao, Zhuqing Shi, et al.. (2017). Caspase polymorphisms and prognosis of hepatocellular carcinoma. PLoS ONE. 12(4). e0176802–e0176802. 7 indexed citations
11.
Na, Rong, Brian T. Helfand, Haitao Chen, et al.. (2017). A genetic variant nearGATA3implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The Prostate. 77(11). 1213–1220. 18 indexed citations
12.
Helfand, Brian T., Carly Conran, Jianfeng Xu, & William J. Catàlona. (2017). A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations. Current Opinion in Urology. 27(5). 475–480. 3 indexed citations
13.
Chen, Haitao, Rong Na, Vignesh T. Packiam, et al.. (2017). Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial. The Prostate. 77(11). 1179–1186. 10 indexed citations
14.
15.
Xu, Jianfeng, Rong Na, Dingwei Ye, et al.. (2016). Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases. Asian Journal of Andrology. 18(4). 525–525. 10 indexed citations
16.
Kearns, James T., et al.. (2016). Clinical validity and utility of genetic risk scores in prostate cancer. Asian Journal of Andrology. 18(4). 509–509. 22 indexed citations
17.
Ilgen, Mark A., Amy S. B. Bohnert, Stephen T. Chermack, et al.. (2016). A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 111(8). 1385–1393. 50 indexed citations
18.
Jiang, Deke, Xiaopan Wu, Xiaopin Ma, et al.. (2015). Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B. Hepatology. 63(4). 1102–1111. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Lamm Breakdown of academic impact, for papers by Polyxeni Dimitropoulou Breakdown of academic impact, for papers by Victor Palit Breakdown of academic impact, for papers by Anastasia Tsagianni Breakdown of academic impact, for papers by Fatma Soliman Elsayed Ebeid Breakdown of academic impact, for papers by James Pine Breakdown of academic impact, for papers by Markus S. Jördens Breakdown of academic impact, for papers by Maria Skondra Breakdown of academic impact, for papers by J Chlumský Breakdown of academic impact, for papers by Hakan Yüceyar
Rankless by CCL
2026